Guselkumab in the treatment of severe hidradenitis suppurativa

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e140-e141. doi: 10.1111/jdv.15368. Epub 2019 Feb 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents / therapeutic use*
  • Female
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Male
  • Severity of Illness Index
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • guselkumab